Related by context. All words. (Click for frequent words.) 74 preserved ejection fraction 72 CYPHER Stent 72 NYHA Class II 71 unstable angina pectoris 71 stable angina 71 symptomatic VTE 71 paroxysmal AF 71 severe mitral regurgitation 71 non valvular atrial 71 nonischemic 71 LV dysfunction 70 resynchronization therapy 70 systolic dysfunction 70 functional mitral regurgitation 69 morphometric vertebral fractures 69 thromboembolic complications 69 postoperative complication 69 ximelagatran 69 myocardial ischemia 69 thrombotic complications 69 decompensated heart failure 69 reinfarction 69 aortic valve stenosis 69 mitral regurgitation 69 angiographic outcomes 69 β blockers 68 postoperative atrial fibrillation 68 undergoing coronary artery 68 XIENCE V PROMUS Stent 68 composite endpoint 68 ATACAND 68 thromboembolic events 68 angiographically 68 revascularizations 68 revascularization procedures 68 valvular disease 68 carotid stenosis 68 ADHF 68 IV NSCLC 68 left ventricular dysfunction 68 coronary stenoses 68 mitral stenosis 68 cryptogenic stroke 68 CTEPH 68 myocardial infarction stroke 68 NATRECOR ® 68 MACCE 67 rFVIIa 67 coronary revascularization 67 pericardial effusion 67 antiarrhythmic drug 67 variceal 67 nonvertebral fracture 67 acute myocardial infarction AMI 67 nondiabetic patients 67 nonoperative treatment 67 CRVO 67 perioperative mortality 67 multivessel disease 67 cardioembolic stroke 67 thromboembolic 67 occlusive disease 67 myocardial infarction MI 67 paroxysmal atrial fibrillation 67 patients undergoing CABG 67 thrombotic events 67 underwent resection 67 angina pectoris 67 AA Amyloidosis 67 recurrent DVT 67 antithrombotic therapy 67 mixed hyperlipidemia 67 ejection fractions 67 atherothrombotic disease 67 intravenous diuretics 66 intravesical therapy 66 NYHA Class III 66 postoperative AF 66 carotid artery blockage 66 artery stenosis 66 hypoperfusion 66 cerebral vasospasm 66 binary restenosis 66 recurrent ischemia 66 nonfatal MI 66 left ventricular systolic 66 paclitaxel eluting stents 66 thromboembolism 66 systolic hypertension 66 vertebral fracture 66 unstable angina UA 66 refractory angina 66 carotid artery stenosis 66 recurrent glioblastoma multiforme 66 arterial thromboembolic events 66 PAOD 66 silent ischemia 66 beta blocker therapy 66 XIENCE V demonstrated 66 nonoperative 66 malperfusion 66 percutaneous interventions 66 coronary intervention 66 elevated IOP 66 chronic thromboembolic pulmonary 66 periprocedural MI 66 acute coronary syndromes 66 symptomatic paroxysmal AF 66 embolic stroke 66 ruboxistaurin 66 sustained ventricular tachycardia 66 intracerebral hemorrhage 66 cardiac resynchronization 65 everolimus eluting stents 65 vertebral compression fractures 65 arteriography 65 nonrandomized 65 arterial thrombosis 65 symptomatic intracranial 65 infarction NSTEMI 65 ipsilateral stroke 65 CRT ICD 65 revascularization procedure 65 defibrillator CRT D 65 femoral neck fracture 65 perioperative morbidity 65 cerebrovascular events 65 TAXUS Stent 65 RE LY ® 65 cardiac tamponade 65 NYHA class 65 hemorrhagic complications 65 systemic embolism 65 cytoreductive surgery 65 hyperacute 65 antiplatelet drugs 65 bypass grafting 65 LVNC 65 noncardiac 65 cardiac dysfunction 65 SSc 65 stent implantation 65 Doxil ® 65 intermittent claudication 65 NATRECOR R 65 perioperative complications 65 CIMZIA ™ 65 intravenous cyclophosphamide 65 postsurgical 65 Venous thromboembolism 65 resuscitated cardiac arrest 65 TNF antagonist 65 atrioventricular block 65 bacterial prostatitis 65 radiochemotherapy 65 dyssynchrony 65 tricuspid regurgitation 65 cardiogenic shock 65 microvascular disease 65 macrovascular events 65 infarctions 65 CYPHER ® Stent 65 hepatorenal syndrome 65 coronary stenosis 65 UA NSTEMI 65 Mitral regurgitation 65 Thrombolysis 65 riociguat 65 occlusion CRVO 65 CIMZIA TM certolizumab pegol 65 patients undergoing percutaneous 65 Neovascular AMD 65 valvular heart 65 spinal metastases 65 OPCAB 65 ventricular dysfunction 65 aortic root replacement 65 nonfatal myocardial infarction 65 proliferative retinopathy 65 thrombocytopenic 65 infective endocarditis 65 atherothrombosis 65 hemodynamically significant 65 unresectable tumors 65 acute coronary syndromes ACS 65 myocardial infarction 64 post thrombotic syndrome 64 periprocedural 64 RVOT 64 myocardial infarctions 64 haematologic 64 acute myocardial infarction 64 hepatectomy 64 pathologic fracture 64 lung resection 64 antiarrhythmic drugs 64 upper gastrointestinal bleeding 64 Afib 64 onset atrial fibrillation 64 chronic periodontitis 64 ischemic complications 64 thrombus aspiration 64 stenoses 64 eplerenone 64 cardiovascular hospitalization 64 recurrent VTE 64 Myocardial Infarction Study 64 octreotide LAR 64 diastolic dysfunction 64 locoregional recurrence 64 dyslipidaemia 64 rosuvastatin #mg 64 recombinant tissue plasminogen 64 coagulopathy 64 aldosterone antagonists 64 atherothrombotic events 64 intracranial hemorrhage ICH 64 Coronary Artery Bypass Graft 64 LVEF 64 severe aortic stenosis 64 locoregional 64 ventricular fibrillation VF 64 KRAS mutations occur 64 bosentan 64 secondary efficacy endpoint 64 lipid lowering therapy 64 MitraClip device 64 ventricular remodeling 64 adrenalectomy 64 prognostic variables 64 hepatic metastases 64 esophagogastric 64 tolvaptan 64 rebleeding 64 ventricular tachyarrhythmia 64 CP CPPS 64 androgen deprivation 64 pulmonary artery banding 64 undergoing CABG 64 percutaneous vertebroplasty 64 LVSD 64 fatal myocardial infarction 64 MADIT II 64 Erythropoietic therapies may 64 invasive candidiasis 64 ruptured aneurysms 64 proliferative diabetic retinopathy 64 microvascular complications 64 FOLFOX4 64 endophthalmitis 64 thrombolytic agents 64 preoperative chemotherapy 64 HeFH 64 cardiovascular hospitalizations 64 vasospasm 64 underwent angiography 64 intracranial stenosis 64 descending thoracic 64 bi ventricular pacing 64 recurrent myocardial infarction 64 aspirin clopidogrel 64 retinal vein occlusion 64 biochemical recurrence 64 HSCT 64 prospectively defined 64 locoregional disease 64 oral anticoagulation 64 curative resection 64 lipid lowering agents 64 vWD 64 ischemic 64 vasculopathy 64 subtrochanteric 64 prospective multicenter study 64 bowel resection 63 carotid artery stenting CAS 63 uncontrolled hypertension 63 recurrent venous thromboembolism 63 CYPHER R Sirolimus eluting 63 macrovascular disease 63 mildly symptomatic 63 cirrhotic patients 63 revascularisation 63 bypass graft CABG surgery 63 valvular heart disease 63 Ischemic 63 fragility fracture 63 cytopenias 63 Eisenmenger syndrome 63 hepatic cirrhosis 63 clinically localized prostate 63 infarct size 63 atherogenic dyslipidemia 63 gastroesophageal junction 63 autonomic dysfunction 63 TAXUS Express Stent 63 pancreatic adenocarcinoma 63 renal artery stenosis 63 percutaneous biopsy 63 acute coronary syndrome 63 Nesiritide 63 candidemia 63 relapsed AML 63 INTEGRILIN R 63 liver transplant recipients 63 ischemic strokes 63 coronary revascularization procedures 63 tachyarrhythmia 63 lumbar spinal stenosis 63 Thal Dex 63 thromboprophylaxis 63 metastatic lung cancer 63 severe exacerbations 63 nonfatal myocardial infarction MI 63 echocardiographic 63 nesiritide 63 failure NYHA 63 elevated triglyceride levels 63 heparin induced thrombocytopenia 63 macular edema secondary 63 neurologic symptoms 63 ischemic vascular 63 INCB# [003] 63 nonfasting triglyceride levels 63 subclinical hypothyroidism 63 ADPKD 63 thromboembolic disease 63 VT VF 63 reoperations 63 candesartan cilexetil 63 valve implantation 63 coronary artery bypass grafts 63 systolic function 63 Postoperative complications 63 ivabradine 63 aortic insufficiency 63 thoracoscopic lobectomy 63 malignant neoplasms 63 Percutaneous Coronary Intervention 63 liver resection 63 Cardiopulmonary bypass 63 hypoxemia 63 keloid scarring 63 OAB symptoms 63 rhythm disturbances 63 ischemic mitral regurgitation 63 transplantation HCT 63 mitral regurgitation MR 63 venous thromboembolic disease 63 macroalbuminuria 63 hemodialysis patients 63 left ventricular hypertrophy 63 progressive dyspnea 63 chronic GVHD 63 Carotid Revascularization Endarterectomy vs. 63 invasive aspergillosis 63 renal insufficiency 63 contractile function 63 idraparinux 63 aldosterone antagonist 63 graft dysfunction 63 ACC AHA 63 diastolic heart 63 sirolimus eluting stents 63 hypercoagulable 63 postoperative infections 63 neurologic progression 63 alteplase 63 ST elevation myocardial 63 acute ischemic stroke 63 postoperative mortality 63 Critical Limb Ischemia CLI 63 symptomatic BPH 63 SYNTAX trial 63 T2DM 63 nonfatal stroke 63 pulmonary resection 63 atherothrombotic 63 neovascular 63 warfarin anticoagulation 63 histologic subtype 63 PSADT 63 mycophenolate mofetil 63 Renal dysfunction 63 NSTE ACS 63 recurrent GBM 63 HIV HCV coinfected 63 ischaemia 63 ischemia 63 osteoporotic vertebral compression fractures 63 cerebral perfusion 63 isolated systolic hypertension 63 cartilage lesions 63 placebo controlled clinical 63 stent restenosis 63 graft occlusion 63 renal tumors 63 arterial thrombotic 63 recurrent ischemic stroke 63 glycated hemoglobin levels 63 CR nPR 63 oral diclofenac 63 malignant neoplasm 63 metastatic renal cell carcinoma 63 acutely decompensated congestive heart 63 pulmonary dysfunction 63 Severe Primary IGFD 63 pulmonary alveolar 63 pyridostigmine 63 left ventricular LV 63 acetabular fractures 62 biliary tract cancer 62 events MACE 62 clevidipine 62 incomplete revascularization 62 vascular abnormalities 62 biventricular pacing 62 radiographic findings 62 hyperkalemia 62 chronic myocardial ischemia 62 recurrent malignant glioma 62 abnormal uterine bleeding 62 renal dysfunction 62 TAXUS Liberte Stent 62 cardiac resynchronisation therapy 62 claudication 62 PNH patients 62 failure ADHF 62 artery bypass 62 mediastinitis 62 microvascular dysfunction 62 Diabetic Macular Edema 62 VaD 62 postoperative morbidity 62 GOUT 62 definite stent thrombosis 62 coronary artery occlusion 62 ICD shocks 62 NYHA functional class 62 atrial arrhythmias 62 fibrosis scarring 62 MGd 62 narrow QRS 62 Relapsing remitting MS 62 homozygous familial hypercholesterolemia 62 osteoid osteoma 62 Cypher Stent 62 colorectal adenoma 62 IIIa inhibitor 62 histologically confirmed 62 anterior uveitis 62 tachyarrhythmias 62 serum calcium levels 62 reintervention 62 COPD exacerbation 62 metastatic GIST 62 perioperatively 62 sonographic findings 62 Aortic stenosis 62 ventricular arrhythmia 62 parathyroidectomy 62 carotid artery stenting 62 pancreatectomy 62 chemoembolization 62 relapsed MM 62 lymphadenectomy 62 neointimal hyperplasia 62 CYPHER ® 62 lobectomy 62 ischemic stroke 62 PsA 62 dilated cardiomyopathy DCM 62 antihypertensive therapy 62 radical nephrectomy 62 varices 62 biventricular 62 variant angina 62 underwent liver transplantation 62 perfusion defects 62 IPAH 62 decompensation 62 angiotensin converting enzyme inhibitors 62 teriflunomide 62 gadolinium enhanced 62 platelet inhibitor 62 colorectal liver metastases 62 lumbar disk herniation 62 ARCOXIA 62 Hypotension 62 hypercholesterolemic patients 62 CoreValve System 62 malignant pleural mesothelioma 62 ANCA associated 62 antiarrhythmic 62 hypercalcemia 62 PSVT 62 Rheos System 62 undergoing coronary angiography 62 intracerebral hemorrhage ICH 62 tirofiban 62 prostate TURP 62 acute aortic dissection 62 Subarachnoid hemorrhage 62 underwent CABG 62 hyperphenylalaninemia HPA due 62 radiotherapy RT 62 ß blockers 62 rt PA 62 TRITON TIMI 62 symptomatic aortic stenosis 62 variceal bleeding 62 DVT PE 62 Atherosclerotic 62 atherosclerotic disease 62 vertebral fractures 62 cerebral angiography 62 Ejection Fraction 62 nephrotoxicity 62 steroid refractory 62 echocardiographic parameters 62 cervical lymph nodes 62 CMV disease 62 de novo lesions 62 Acute Decompensated Heart Failure 62 dysfunction LVSD 62 deep venous thromboses 62 chemoradiotherapy 62 serum phosphate 62 antireflux surgery 62 renal biopsy 62 gastroduodenal 62 NMIBC 62 artery occlusion 62 LV ejection fraction 62 acute decompensated heart 62 intima media thickness 62 cardiac allograft vasculopathy 62 nonobstructive CAD 62 subgroup analyzes 62 acute decompensation 62 antiplatelet medications 62 metachronous 62 aortic regurgitation 62 EchoCRT 62 ventricular tachycardia VT 62 thoracic aortic 62 retransplantation 62 EXJADE 62 defibrillator implantation 62 metastatic malignant melanoma 62 Class IIIb 62 ICD implantation 62 cerebral ischemia 62 FluCAM arm 62 posaconazole 62 primary aldosteronism 62 Surgical resection 62 TAXUS VI 62 evaluable 62 myocardial fibrosis 62 debilitating complication 62 HF hospitalization 62 pyelonephritis 62 cryptogenic 62 catheter occlusion 62 valvular 62 ablation procedures 62 TAXUS stent 62 sotalol 62 liver histology 62 VAPRISOL 62 Mitral valve repair 62 myocardial ischaemia 62 unstable angina 62 NNT = 62 intravenous bisphosphonates 62 simvastatin ezetimibe 62 TAVR 62 choroidal neovascularization 62 hemodynamic instability 62 angioplasty stenting 62 fibrinolysis 62 opioid analgesia 62 MTWA testing 61 argatroban 61 alemtuzumab treated 61 segment elevation myocardial 61 endothelial keratoplasty 61 REOPRO 61 reperfusion therapy 61 dobutamine 61 pretransplant 61 prostate cancer CaP 61 FFR measurements 61 urolithiasis 61 colectomy 61 osteoporotic compression fractures 61 IOP lowering 61 mRCC 61 cardiomyopathies 61 haemodynamic 61 transesophageal echocardiography 61 femoral neck fractures 61 carcinomatosis 61 thrombolytic therapy 61 ACUITY trial 61 antiangiogenic therapy 61 PROactive study 61 squamous histology 61 tenecteplase 61 BENICAR HCT 61 fluvastatin 61 Natalizumab 61 atrial fibrillation AF 61 relapsed SCLC 61 sinus node dysfunction 61 intracerebral haemorrhage 61 ICD implants 61 esophagectomy 61 extrapyramidal symptoms 61 peripheral arterial occlusive disease 61 renal impairment 61 sirolimus stent 61 anastomotic leak 61 intracardiac 61 pre operatively 61 prolonged QT interval 61 revascularization 61 Non inferiority 61 coronary artery revascularization 61 chemoradiation therapy 61 posttransplant 61 pericardial effusions 61 femoral shaft fractures 61 mitral valve regurgitation 61 interstitial pneumonitis 61 electrophysiologic 61 underwent coronary angiography 61 Catheter ablation 61 pathologic fractures 61 ejection fraction 61 evaluating CK # 61 T1DM 61 angiographic restenosis 61 oral rivaroxaban 61 Aortic valve 61 retrospective cohort 61 dimensional echocardiography 61 RSD# oral 61 prostate carcinoma 61 cardiac resynchronization therapy 61 syncopal 61 retinal vein occlusion induced 61 cilostazol 61 drug eluting stent implantation 61 inotropes 61 peri procedural 61 Kaplan Meier analysis 61 STRIDE PD 61 carcinoids 61 pseudoaneurysm 61 coronary stenting 61 Carotid endarterectomy 61 thromboses 61 myocardial infarct 61 fraction LVEF 61 nadolol 61 PSA nadir 61 thiazide diuretic 61 infarcts 61 carotid endarterectomy CEA 61 percutaneous transluminal coronary angioplasty 61 acute humoral rejection 61 neurological manifestations 61 valvulopathy 61 neovascular AMD 61 aHUS 61 TNF alpha inhibitor 61 ARIXTRA 61 aminotransferases 61 oxycodone CR 61 carcinoid 61 azacitidine 61 CABG coronary artery 61 onset seizures 61 cystic lesions 61 hyperglycaemia 61 coronary vessels 61 anthracycline therapy 61 Chronic Heart Failure 61 metastatic RCC 61 Adjuvant chemotherapy 61 OSAHS 61 myocardial infarction ventricular fibrillation 61 extrapleural pneumonectomy 61 Toxicities 61 gemcitabine Gemzar 61 NAVISTAR R 61 ejection fraction EF 61 QTc prolongation 61 contrast echocardiography 61 renal scarring 61 Intracranial 61 cortical dysplasia 61 salmeterol fluticasone 61 evaluable subjects 61 NYHA 61 wound dehiscence 61 intracranial hypertension 61 NEVO 61 spinal cord compression 61 cardiac biomarkers 61 coinfected patients 61 tricuspid 61 GORE TAG Device 61 elevated troponin 61 either acutely decompensated 61 leukemia AML 61 oral anticoagulant therapy 61 Occlusive Disease 61 H. pylori eradication 61 AGILECT R 61 repeat revascularization 61 DAPT 61 medically refractory 61 airflow limitation 61 Heavy menstrual bleeding 61 diabetic kidney 61 HoFH 61 valve regurgitation 61 reflux disease GERD 61 arthropathy 61 neurologic complications 61 adverse cytogenetics 61 target vessel revascularization 61 dopaminergic therapy 61 adnexal mass 61 FFR guided treatment 61 restenosis reblockage 61 candesartan 61 complement inhibitor eculizumab 61 intracranial bleeding 61 hemodynamically stable 61 antimicrobial prophylaxis 61 stage IIIB 61 malignant pleural effusion 61 total thyroidectomy 61 refractory AML 61 jugular venous 61 Taxus Stent 61 leiomyomas 61 carotid IMT 61 irbesartan 61 aneurysmal subarachnoid hemorrhage 61 angina chest 61 transurethral resection 61 resectable 61 Atypical Hemolytic Uremic Syndrome 61 mitral insufficiency 61 superficial femoral 61 undergone radical prostatectomy 61 detrusor overactivity 61 Idiopathic pulmonary fibrosis 61 clot busting therapy 61 deferiprone 61 Chronic pancreatitis 61 gadobutrol 61 unfractionated heparin UFH 61 TMP SMX 61 VADT 61 hsCRP levels 61 acetabular fracture 61 transaminase elevations 61 cerebrovascular accident 61 CYPHER R Stent 61 hypercholesterolaemia 61 thyrotoxicosis 61 intra abdominal abscess 61 benign prostatic hypertrophy BPH 61 Coronary artery bypass graft 61 graft patency 61 obstructive coronary artery 61 MADIT CRT trial 61 metastatic bone 61 noncardiac surgery 61 intraoperative complications 61 PRADAXA #mg 61 unresectable 61 IBS C 61 CABG surgeries 61 asymptomatic carotid stenosis 61 arterial grafts 61 dosage regimens 61 oral FTY# 61 diastolic blood pressures 61 radical retropubic prostatectomy 61 PLX STROKE targeting 61 percutaneous coronary interventions 61 histologically 61 postoperative pulmonary 61 hypervascular tumors 61 atrial pacing 61 thoracic aortic aneurysms 61 venous reflux 61 renal denervation 61 extracranial 61 severe renal impairment 61 PASI scores 61 Ebstein anomaly 61 reflux esophagitis 61 TEAEs 61 oral Hycamtin 61 recurrent glioma 61 biochemical relapse 61 STEMIs 61 pheochromocytoma 61 glycoprotein IIb IIIa inhibitors 61 CARE HF 61 death reinfarction 61 thrombolytics 61 nonischemic cardiomyopathy 61 cinacalcet 61 elective PCI 61 diabetes mellitus DM 61 induced macular edema 61 laser photocoagulation 61 gastric adenocarcinoma 61 bullous 61 intravitreal injections 61 TAXUS Stents 61 neurogenic bladder 61 recurrent glioblastoma 61 hepatic encephalopathy HE 61 Ivabradine 61 deep vein thromboses 61 myocardial viability 61 microangiopathy 61 nephron sparing surgery 61 Diabetic nephropathy 61 kidney transplant recipients 61 gastrointestinal GI motility disorders 61 nonvertebral fractures 61 coronary artery stenosis 60 pulmonary metastasis 60 erythema nodosum 60 Acute Myocardial Infarction AMI 60 histological subtypes 60 Dacogen decitabine 60 dacarbazine DTIC 60 mL/min/#.# m 2 60 radical prostatectomy RP 60 plasma creatinine 60 fragility fractures 60 postoperative delirium 60 Cimzia TM 60 FOLPI 60 noncardiovascular mortality 60 hyperalgesia 60 IRX 2 60 venous hypertension 60 efficacy endpoint 60 diabetic retinopathy DR 60 osteoporotic vertebral fractures 60 VIIBRYD 60 Acute Coronary Syndrome 60 pulmonary capillary wedge 60 CNS systemic embolism 60 acute exacerbation 60 Stent thrombosis 60 pulmonary embolism PE 60 tapentadol ER 60 lamivudine monotherapy 60 arterial revascularization 60 symptomatic carotid stenosis 60 lumbar disc herniation 60 colorectal carcinoma 60 immunosuppressive regimen 60 hepatocellular carcinomas 60 Subgroup analysis 60 antithrombotics 60 allogeneic stem cell 60 MGUS 60 Aggrastat ® tirofiban hydrochloride 60 glomerular filtration 60 cardiovascular mortality 60 stenting procedures 60 undergoing radical prostatectomy 60 coronary artery disease 60 coronary blockages 60 ventricular dilation 60 Arrhythmias 60 chlorambucil 60 parkinsonian symptoms 60 nicardipine 60 atrioventricular valve 60 unstable angina chest 60 pamidronate 60 Unstable Angina 60 HBeAg negative 60 postmenopausal osteoporotic women 60 unresectable stage 60 intra arterial 60 diameter stenosis 60 concurrent chemoradiation 60 NSTEMI 60 cirrhotic 60 symptomatic hyponatremia 60 lung metastases 60 infarction STEMI 60 inotropic therapy 60 TORISEL 60 coronary interventions 60 stented 60 mcg albinterferon alfa 2b 60 oncologic outcomes 60 antiarrhythmic medications 60 percutaneous intervention 60 femoral shaft fracture 60 hepatic lesions 60 mm Stent 60 intracranial aneurysms 60 neoadjuvant chemotherapy 60 tumor resection 60 prospectively stratified 60 anti arrhythmic drug 60 Uncontrolled hypertension 60 elevated LDH 60 electrical cardioversion 60 recanalization 60 statistically significant p = 60 renal allograft 60 transcatheter closure 60 pain palliation 60 GP IIb IIIa inhibitors 60 femoral fractures 60 arteriolar 60 acetabular dysplasia 60 myocardial infarction congestive heart 60 aneurysm rupture 60 juvenile idiopathic arthritis 60 leukocyte count 60 symptomatic ischemic 60 contralateral breast 60 non metastatic osteosarcoma 60 ACTEMRA TM 60 Procoralan 60 delayed CINV 60 hepatotoxicity 60 VTE prophylaxis 60 pCR 60 anticoagulant warfarin 60 macrovascular 60 ischemic lesions 60 Cardiogenic shock 60 portal vein thrombosis 60 unresectable HCC 60 Coronary artery bypass grafting 60 aortic stenosis 60 tumor lysis syndrome 60 landmark ATHENA trial 60 RECIST Response Evaluation Criteria 60 lipid lowering drugs 60 prospective randomized multicenter 60 Acute Myocardial Infarction 60 Critical limb ischemia 60 radicular pain 60 LVRS 60 anticoagulation therapy 60 cystoid macular edema 60 anemia neutropenia 60 Cardiac Resynchronization Therapy 60 urothelial cancer 60 surgical debulking 60 drotrecogin alfa activated 60 Postoperative 60 gastrointestinal perforation 60 conventional angiography 60 severe neutropenia 60 Fibrillex TM 60 ischemia driven 60 Microplasmin 60 proximal DVT 60 T2 lesions 60 GI motility disorders 60 epidural steroid injections 60 cerebral infarction 60 thrombocytosis 60 contrast induced nephropathy 60 familial hypercholesterolemia 60 hypercalcaemia 60 warfarin therapy 60 malabsorptive 60 noninferiority 60 Subgroup analyzes 60 Hydroxyurea 60 comorbid conditions 60 moderate renal impairment 60 supraventricular arrhythmias 60 XIENCE V stent